Diffusion tensor imaging to determine effects of antidementive treatment on cerebral structural connectivity in Alzheimer's disease

Current Pharmaceutical Design

Volumn 19, Issue 36, 2013, Pages 6416-6425

  Kilimann, Ingo ^a,b   Likitjaroen, Yuttachai ^c   Hampel, Harald ^d   Teipel, Stefan ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Early diagnosis; Mild cognitive impairment; Neuronal integrity; Tissue structure

Indexed keywords

DONEPEZIL; GALANTAMINE; MYELIN; PLACEBO; RIVASTIGMINE;

ADOLESCENCE; AGING; ALZHEIMER DISEASE; ANISOTROPY; ASSOCIATION; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN SIZE; CEREBELLUM VERMIS; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE REHABILITATION; COGNITIVE THERAPY; CONNECTOME; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MILD COGNITIVE IMPAIRMENT; MYELINATION; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PRIORITY JOURNAL; RELATIVE ANISOTROPY; REVIEW; SENILE PLAQUE; TRACTOGRAPHY; VOXEL BASED MORPHOMETRY; WHITE MATTER; WORKING MEMORY;

AGING; ALZHEIMER DISEASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; DIFFUSION TENSOR IMAGING; HUMANS; NEURAL PATHWAYS; NEUROIMAGING;

EID: 84887922621     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319360003     Document Type: Review

References (123)

1. Geschwind N. Disconnexion syndromes in animals and man. I. Brain 1965; 88: 237-94.
2. Geschwind N. Disconnexion syndromes in animals and man. II. Brain 1965; 88: 585-644.
3. Siemens G. Connectivism. A learning theory for the digital age. Elearnspace 2004.
4. Filley CM. White matter: beyond focal disconnection. Neurol Clin 2011; 29: 81-97, viii.
5. Bracco L, Piccini C, Moretti M, et al. Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord 2005; 20: 358-66.
6. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145-51.
7. Pearson RC, Esiri MM, Hiorns RW, Wilcock GK, Powell TP. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 1985; 82: 4531-4.
8. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 1990; 83: 445-57.
9. Hampel H, Teipel SJ, Alexander GE, et al. Corpus callosum atrophy is a possible indicator of region-and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 1998; 55: 193-8.
10. Teipel SJ, Reuter S, Stieltjes B, et al. Multicenter stability of diffusion tensor imaging measures: a European clinical and physical phantom study. Psychiatry Res 2011; 194: 363-71.
11. Fischer FU, Scheurich A, Wegrzyn M, et al. Automated tractography of the cingulate bundle in Alzheimer's disease: A multicenter DTI study. J Magn Reson Imaging 2012.
12. Teipel SJ, Wegrzyn M, Meindl T, et al. Anatomical MRI and DTI in the Diagnosis of Alzheimer's Disease: A European Multicenter Study. J Alzheimers Dis 2012; in press.
13. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 2011; 10: 819-28.
14. Jack CR, Jr., Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 257-62.
15. Muramori F, Kobayashi K, Nakamura I. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases. Psychiatry Clin Neurosci 1998; 52: 593-9.
16. Nelson PT, Jicha GA, Schmitt FA, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol 2007; 66: 1136-46.
17. Delbeuck X, Van der Linden M, Collette F. Alzheimer's disease as a disconnection syndrome? Neuropsychol Rev 2003; 13: 79-92.
18. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991; 82: 239-59.
19. Flechsig P. Developmental (myelogenetic) localization of the cerebral cortex in human subject. Lancet 1901; 2: 1027-1029.
20. Reisberg B, Franssen EH, Hasan SM, et al. Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. Eur Arch Psychiatry Clin Neurosci 1999; 249 Suppl 3: 28-36.
21. Arendt T, Bruckner MK, Gertz HJ, Marcova L. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 1998; 83: 991-1002.
22. Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 1996; 92: 197-201.
23. Lintl P, Braak H. Loss of intracortical myelinated fibers: a distinctive age-related alteration in the human striate area. Acta Neuropathol 1983; 61: 178-82.
24. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings JL. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 2004; 25: 843-51.
25. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4: 469-80.
26. Le Bihan D. Theoretical principles of perfusion imaging. Application to magnetic resonance imaging. Invest Radiol 1992; 27 Suppl 2: S6-11.
27. Cleveland GG, Chang DC, Hazlewood CF, Rorschach HE. Nuclear magnetic resonance measurement of skeletal muscle: anisotrophy of the diffusion coefficient of the intracellular water. Biophys J 1976; 16: 1043-53.
28. Sundgren PC, Dong Q, Gomez-Hassan D, Mukherji SK, Maly P, Welsh R. Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology 2004; 46: 339-50.
29. Basser PJ, Mattiello J, LeBihan D. Estimation of the effective selfdiffusion tensor from the NMR spin echo. J Magn Reson B 1994; 103: 247-54.
30. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996; 36: 893-906.
31. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003; 45: 169-84.
32. Turner MR, Grosskreutz J, Kassubek J, et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 2011; 10: 400-3.
33. Westin CF, Maier SE, Mamata H, Nabavi A, Jolesz FA, Kikinis R. Processing and visualization for diffusion tensor MRI. Med Image Anal 2002; 6: 93-108.
34. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 2006; 26 Suppl 1: S205-23.
35. Le Bihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995; 8: 375-86.
36. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996; 111: 209-19.
37. Jones DK, Pierpaoli C. Confidence mapping in diffusion tensor magnetic resonance imaging tractography using a bootstrap approach. Magn Reson Med 2005; 53: 1143-9.
38. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001; 13: 534-46.
39. Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 1995; 8: 333-44.
40. Budde MD, Xie M, Cross AH, Song SK. Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 2009; 29: 2805-13.
41. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005; 26: 132-40.
42. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001; 11: 107-16.
43. Madler B, Drabycz SA, Kolind SH, Whittall KP, MacKay AL. Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn Reson Imaging 2008; 26: 874-88.
44. Juraska JM, Lowry NC. Neuroanatomical Changes Associated with Cognitive Aging. Curr Top Behav Neurosci 2011.
45. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magn Reson Med 2000; 44: 625-32.
46. Conturo TE, Lori NF, Cull TS, et al. Tracking neuronal fiber pathways in the living human brain. Proc Natl Acad Sci USA 1999; 96: 10422-7.
47. Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. DTI analyses and clinical applications in Alzheimer's disease. J Alzheimers Dis 2011; 26 Suppl 3: 287-96.
48. Jones DK, Griffin LD, Alexander DC, et al. Spatial normalization and averaging of diffusion tensor MRI data sets. Neuroimage 2002; 17: 592-617.
49. Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 1999; 56: 367-74.
50. Moseley M, Bammer R, Illes J. Diffusion-tensor imaging of cognitive performance. Brain Cogn 2002; 50: 396-413.
51. Johansen-Berg H, Rushworth MF. Using diffusion imaging to study human connectional anatomy. Annu Rev Neurosci 2009; 32: 75-94.
52. Lazar M, Weinstein DM, Tsuruda JS, et al. White matter tractography using diffusion tensor deflection. Hum Brain Mapp 2003; 18: 306-21.
53. Masutani Y, Aoki S, Abe O, Hayashi N, Otomo K. MR diffusion tensor imaging: recent advance and new techniques for diffusion tensor visualization. Eur J Radiol 2003; 46: 53-66.
54. Nucifora PG, Verma R, Lee SK, Melhem ER. Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007; 245: 367-84.
55. Behrens TE, Johansen-Berg H, Woolrich MW, et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003; 6: 750-7.
56. Parker GJ, Haroon HA, Wheeler-Kingshott CA. A framework for a streamline-based probabilistic index of connectivity (PICo) using a structural interpretation of MRI diffusion measurements. J Magn Reson Imaging 2003; 18: 242-54.
57. Cercignani M, Bammer R, Sormani MP, Fazekas F, Filippi M. Inter-sequence and inter-imaging unit variability of diffusion tensor MR imaging histogram-derived metrics of the brain in healthy volunteers. AJNR Am J Neuroradiol 2003; 24: 638-43.
58. Pfefferbaum A, Adalsteinsson E, Sullivan EV. Replicability of diffusion tensor imaging measurements of fractional anisotropy and trace in brain. J Magn Reson Imaging 2003; 18: 427-33.
59. Vollmar C, O'Muircheartaigh J, Barker GJ, et al. Identical, but not the same: intra-site and inter-site reproducibility of fractional anisotropy measures on two 3. 0T scanners. Neuroimage 2010; 51: 1384-94.
60. Hasan KM, Kamali A, Iftikhar A, et al. Diffusion tensor tractography quantification of the human corpus callosum fiber pathways across the lifespan. Brain Res 2009; 1249: 91-100.
61. Kochunov P, Williamson DE, Lancaster J, et al. Fractional anisotropy of water diffusion in cerebral white matter across the lifespan. Neurobiol Aging 2012; 33: 9-20.
62. Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage 2012; 60: 340-52.
63. Budde MD, Kim JH, Liang HF, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med 2007; 57: 688-95.
64. Sullivan EV, Adalsteinsson E, Hedehus M, et al. Equivalent disruption of regional white matter microstructure in ageing healthy men and women. Neuroreport 2001; 12: 99-104.
65. Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E, Moseley M. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magnetic Resonance in Medicine 2000; 44: 259-268.
66. Salat DH, Tuch DS, Greve DN, et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiology of Aging 2005; 26: 1215-1227.
67. Bhagat YA, Beaulieu C. Diffusion anisotropy in subcortical white matter and cortical gray matter: Changes with aging and the role of CSF-suppression. Journal of Magnetic Resonance Imaging 2004; 20: 216-227.
68. Beaulieu C, Plewes C, Paulson LA, et al. Imaging brain connectivity in children with diverse reading ability. Neuroimage 2005; 25: 1266-1271.
69. Schmithorst VJ, Wilke M, Dardzinski BJ, Holland SK. Cognitive functions correlate with white matter architecture in a normal pediatric population: a diffusion tensor MRI study. Hum Brain Mapp 2005; 26: 139-47.
70. Mabbott DJ, Rovet J, Noseworthy MD, Smith ML, Rockel C. The relations between white matter and declarative memory in older children and adolescents. Brain Res 2009; 1294: 80-90.
71. Fryer SL, Frank LR, Spadoni AD, et al. Microstructural integrity of the corpus callosum linked with neuropsychological performance in adolescents. Brain Cogn 2008; 67: 225-33.
72. Kantarci K, Senjem ML, Avula R, et al. Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology 2011; 77: 26-34.
73. Xiong C, Roe CM, Buckles V, et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Arch Neurol 2011; 68: 1313-9.
74. Bendlin BB, Ries ML, Canu E, et al. White matter is altered with parental family history of Alzheimer's disease. Alzheimers Dement 2010; 6: 394-403.
75. Sullivan EV, Rohlfing T, Pfefferbaum A. Longitudinal study of callosal microstructure in the normal adult aging brain using quantitative DTI fiber tracking. Developmental Neuropsychology 2010; 35: 233-56.
76. Barrick TR, Charlton RA, Clark CA, Markus HS. White matter structural decline in normal ageing: a prospective longitudinal study using tract-based spatial statistics. Neuroimage 2010; 51: 565-77.
77. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986; 19: 253-62.
78. Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992; 115 (Pt 3): 735-48.
79. Barber R, Scheltens P, Gholkar A, et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999; 67: 66-72.
80. Gouw AA, Seewann A, Vrenken H, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008; 131: 3286-98.
81. Kantarci K, Jack CR, Jr., Xu YC, et al. Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 2001; 219: 101-7.
82. Sandson TA, Felician O, Edelman RR, Warach S. Diffusionweighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord 1999; 10: 166-71.
83. Fellgiebel A, Wille P, Muller MJ, et al. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 2004; 18: 101-8.
84. Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J Neurol Sci 1998; 156: 195-200.
85. Naggara O, Oppenheim C, Rieu D, et al. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res 2006; 146: 243-9.
86. Bozzali M, Falini A, Franceschi M, et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2002; 72: 742-6.
87. Choi SJ, Lim KO, Monteiro I, Reisberg B. Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J Geriatr Psychiatry Neurol 2005; 18: 12-9.
88. Medina D, DeToledo-Morrell L, Urresta F, et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 2006; 27: 663-72.
89. Rose SE, Chen F, Chalk JB, et al. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2000; 69: 528-30.
90. Teipel SJ, Stahl R, Dietrich O, et al. Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage 2007; 34: 985-95.
91. Kubicki M, Shenton ME, Salisbury DF, et al. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 2002; 17: 1711-9.
92. Giuliani NR, Calhoun VD, Pearlson GD, Francis A, Buchanan RW. Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia. Schizophr Res 2005; 74: 135-47.
93. Nakata Y, Aoki S, Sato N, Yasmin H, Masutani Y, Ohtomo K. Tract-specific analysis for investigation of Alzheimer disease: a brief review. Jpn J Radiol 2010; 28: 494-501.
94. Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Markesbery WR. Age and gender effects on human brain anatomy: a voxelbased morphometric study in healthy elderly. Neurobiol Aging 2007; 28: 1075-87.
95. Liu Y, Spulber G, Lehtimaki KK, et al. Diffusion tensor imaging and Tract-Based Spatial Statistics in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2011; 32: 1558-71.
96. Chua TC, Wen W, Chen X, et al. Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment. Am J Geriatr Psychiatry 2009; 17: 602-13.
97. Stricker NH, Schweinsburg BC, Delano-Wood L, et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage 2009; 45: 10-6.
98. Zhuang L, Wen W, Zhu W, et al. White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage 2010; 53: 16-25.
99. Pagani E, Hirsch JG, Pouwels PJ, et al. Intercenter differences in diffusion tensor MRI acquisition. J Magn Reson Imaging 2010; 31: 1458-68.
100. Teipel SJ, Ewers M, Wolf S, et al. Multicentre variability of MRIbased medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res 2010; 182: 244-50.
101. Teipel SJ, Meindl T, Wagner M, et al. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 2010; 22: 507-22.
102. Buschert VC, Teipel SJ, Hampel H, Burger K. [Current status of cognition-based interventions in Alzheimer's disease]. Nervenarzt 2009; 80: 273-87.
103. Buschert V, Bokde AL, Hampel H. Cognitive intervention in Alzheimer disease. Nat Rev Neurol 2010; 6: 508-17.
104. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane database of systematic reviews (Online) 2003: CD003260.
105. Craik FI, Winocur G, Palmer H, et al. Cognitive rehabilitation in the elderly: effects on memory. J Int Neuropsychol Soc 2007; 13: 132-42.
106. Keller TA, Just MA. Altering cortical connectivity: remediationinduced changes in the white matter of poor readers. Neuron 2009; 64: 624-31.
107. Lovden M, Bodammer NC, Kuhn S, et al. Experience-dependent plasticity of white-matter microstructure extends into old age. Neuropsychologia 2010; 48: 3878-83.
108. Engvig A, Fjell AM, Westlye LT, et al. Memory training impacts short-term changes in aging white matter: A Longitudinal Diffusion Tensor Imaging Study. Hum Brain Mapp 2011.
109. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006: CD005593.
110. Hashimoto M, Kazui H, Matsumoto K, Nakano Y, Yasuda M, Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Am J Psychiatry 2005; 162: 676-82.
111. Venneri A, Lane R. Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease. Neuroreport 2009; 20: 285-8.
112. Bokde AL, Karmann M, Teipel SJ, et al. Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study. J Clin Psychopharmacol 2009; 29: 147-56.
113. Goveas JS, Xie C, Ward BD, et al. Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI. J Magn Reson Imaging 2011; 34: 764-73.
114. Venneri A, Shanks MF, Staff RT, et al. Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease. Neuroreport 2002; 13: 83-7.
115. Teipel SJ, Drzezga A, Bartenstein P, Moller HJ, Schwaiger M, Hampel H. Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a doubleblind cross-over trial. Psychopharmacology (Berl) 2006; 187: 86-94.
116. Tune L, Tiseo PJ, Ieni J, et al. Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebo-controlled study. Am J Geriatr Psychiatry 2003; 11: 169-77.
117. Devine ME, Fonseca JA, Walker RW, Sikdar T, Stevens T, Walker Z. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study. Int J Geriatr Psychiatry 2007; 22: 1120-6.
118. Likitjaroen Y, Meindl T, Friese U, et al. Longitudinal changes of fractional anisotropy in Alzheimer's disease patients treated with galantamine: a 12-month randomized, placebo-controlled, doubleblinded study. Eur Arch Psychiatry Clin Neurosci 2011.
119. Jones DK, Catani M, Pierpaoli C, et al. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp 2006; 27: 230-8.
120. Weaver KE, Richards TL, Liang O, Laurino MY, Samii A, Aylward EH. Longitudinal diffusion tensor imaging in Huntington's Disease. Exp Neurol 2009; 216: 525-9.
121. Andersen K, Andersen BB, Pakkenberg B. Stereological quantification of the cerebellum in patients with Alzheimer's disease. Neurobiol Aging 2012; 33: 197 e11-20.
122. Schroeter ML, Stein T, Maslowski N, Neumann J. Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 2009; 47: 1196-206.
123. Li TQ, Wahlund LO. The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques. Acta Radiol 2011; 52: 211-22.